semaglutide cause low blood sugar Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, gallbladder disease, dehydration-related acute kidney injury 14 Dangerous Risks of Taking

Summary: Retatrutide has not been formally linked to hair loss in published data, but its pronounced weight loss effect may trigger telogen effluvium a temporary, nutritionally driven hair shedding as seen with other incretin-based therapies

Therefore, evidence of the comparative cost-effectiveness of GLP-1RAs versus insulin therapy from the present study could support the formulation of healthcare reimbursement policies in real-world clinical practice

Accounts for approximately 38.6% of the market in 2025 and is growing at the faster CAGR of 17.2% through 2034

But thanks to the approval of a Victoza generic by the US Food and Drug Administration (FDA) in December 2024, patients now have access to another generic GLP-1

Since they are highly rebated in 2026 and 2027 list is around 2026 net for employers, I would imagine little to no rebate in 2027